Fiche centre
McGill University
Montreal — Canada
Essais liés10clinical trials
VilleMontreallocalisation
PaysCanadalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07883590
Essais cliniques associés
10| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| JNJ-63733657 | Alzheimer | Phase 2 | NCT04619420 | Autonomy — A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease | TERMINATED |
| LY3873862 | Sclérose latérale amyotrophique | Phase 1 | NCT07883590 | A Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS). | NOT_YET_RECRUITING |
| 18F-Flortaucipir radiopharmaceutical | Alzheimer | Phase 1 | NCT05361382 | Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease | ACTIVE_NOT_RECRUITING |
| Lab Assay for seven genetic variants for Parkinson's Disease | Parkinson | À vérifier | NCT04994015 | Parkinson's Foundation PD GENEration Genetic Registry | RECRUITING |
| VX-670 | Myopathies | Phase 1/2 | NCT06185764 | Galileo — A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1) | ACTIVE_NOT_RECRUITING |
| FSHD — Dietary Protein Requirements in Adults With Facioscapulohumeral Muscular Dystrophy | Myopathies | Non applicable | NCT06785428 | FSHD — Dietary Protein Requirements in Adults With Facioscapulohumeral Muscular Dystrophy | COMPLETED |
| Nipocalimab | Myasthénie | Phase 3 | NCT04951622 | A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | RECRUITING |
| SRP-1001 for Injection | Myopathies | Phase 1/2 | NCT06131983 | Study of SRP-1001 in Adult and Adolescent Participants With Facioscapulohumeral Muscular Dystrophy Type 1 | ENROLLING_BY_INVITATION |
| SRP-1003 IV Infusion | Myopathies | Phase 1/2 | NCT06138743 | Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy | ENROLLING_BY_INVITATION |
| Effect of Palifermin on Skin Tumors in Patients Undergoing Bone Marrow Transplantation | Cancer | À vérifier | NCT00610818 | Effect of Palifermin on Skin Tumors in Patients Undergoing Bone Marrow Transplantation | TERMINATED |